Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Financial Results

Set Alert for Financial Results

Latest From Financial Results

ImmuCell sales drop in Q2 as First Defense passes peak

US animal health firm ImmuCell has seen its sales dip by 26% in the second quarter of 2017.

Financial Results R&D

Jaguar Q2 revenues boosted by collaborations

Jaguar Health has seen a huge financial hike in the second quarter of 2017, driven by collaborative revenues.

Jaguar Animal Health Financial Results

Zomedica reports wider net loss as it ramps up R&D

Ann Arbor, Michigan-based Zomedica has posted a higher net loss in the second quarter of 2017 as it continues to invest in R&D and commercialization strategies.

Financial Results R&D

Alivira Q1 sees revenues almost double

Alivira Animal Health's transformation into a leading industry player has continued into the first quarter of its fiscal 2018. 

Financial Results Alivira Animal Health

Boehringer rivals Zoetis' top spot as H1 highlights duel between innovation and acquisition

Half-way through fiscal 2017, most of the leading animal health companies are enjoying strong growth. The last six months has encapsulated how the industry leaders are boosting their top lines organically and via various sizes of acquisitions. Animal Pharm editor Joseph Harvey maps out a shifting top 10 ranking in animal health.
Financial Results M&A

Henry Schein Q2 sales boosted by strong performance in US

Henry Schein has posted positive growth of 4.4% for its animal health division in the second quarter of 2017.

Financial Results Henry Schein
See All